Month: June 2020

Livongo Studies Leverage Proprietary Data and Remote Monitoring to Reveal Unique Diabetes Management Insights

Written by Customer Service on June 18, 2020. Posted in Public Companies.

MOUNTAIN VIEW, Calif., June 18, 2020 (GLOBE NEWSWIRE) — Livongo Health, Inc. (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of two studies that demonstrate how remote monitoring technologies can utilize continuous and unique data insights via its AI+AI® engine to better inform care decisions and outcomes. The research findings were presented at the American Diabetes Association’s 80th Scientific Sessions: A Virtual Experience held on June 12-16, 2020. The first study, Predictors of Emergency Department and Inpatient Admissions after Hypo- and Hyperglycemic Events: Leveraging Remote Monitoring Data of People with Diabetes, included 7,633 study participants and used Livongo’s cellular-enabled blood glucose monitor...

Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)

Written by Customer Service on June 18, 2020. Posted in Public Companies.

First Approved Therapy in the United States for Patients with TIO Who Cannot Undergo Surgical Removal of TumorsTIO is Second FDA-Approved Indication for Crysvita, Which is Also Approved for the Treatment of X-linked Hypophosphatemia (XLH)NOVATO, Calif. and TOKYO, June 18, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions using the latest biotechnology, today announced that the U.S. Food and Drug Administration (FDA) has approved Crysvita® (burosumab) for the treatment of fibroblast growth factor 23 (FGF23)-related hypophosphatemia in tumor-induced osteomalacia...

Ipsidy To Hold Web Conference on June 25, 2020

Written by Customer Service on June 18, 2020. Posted in Public Companies.

LONG BEACH, NY , June 18, 2020 (GLOBE NEWSWIRE) — Ipsidy Inc. (www.ipsidy.com) [OTCQB: IDTY], a leading provider of secure, mobile biometric identity solutions, including Identity as a Service (IDaaS) announces it will hold a web-conference on June 25, 2020 at 1.00 p.m. Eastern time.The web conference will be led by newly appointed CEO Phillip Kumnick. Ipsidy will present our vision for the future of the growing digital identity market, provide updates on new strategic initiatives, and share the latest enhancements to our identity platform.View demonstrations of Ipsidy’s solutions in action, and learn how enterprise customers are building identity trust across a range of applications in financial services, eCommerce, healthcare, and online to offline marketplaces.A replay, as well as a copy of the slide presentations will...

RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK

Written by Customer Service on June 18, 2020. Posted in Public Companies.

The multi-center, randomized, double-blind, parallel-arm, placebo-controlled Phase 2/3 clinical study with opaganib in 270 severe COVID-19 patients is planned to be conducted in up to 40 clinical sites across Russia, Italy, the UK and additional countries—In parallel, a clinical study of opaganib in up to 40 severe COVID-19 patients has been approved by the FDA and is open for recruitment in the U.S.TEL-AVIV, Israel and RALEIGH, N.C., June 18, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it has submitted Clinical Trial Applications (CTA) with the UK Medicines & Healthcare Products Regulatory Agency (MHRA) and the Italian Medicines Agency (AIFA) for a Phase 2/3 clinical study evaluating opaganib (Yeliva®, ABC294640)1...

SAFR Facial Recognition Now Runs On The AXIS Camera Application Platform (ACAP)

Written by Customer Service on June 18, 2020. Posted in Public Companies.

Seattle, June 18, 2020 (GLOBE NEWSWIRE) — SAFR from RealNetworks, Inc. (NASDAQ: RNWK), today announced SAFR® Inside, a new app component of its Facial Recognition and Computer Vision Platform that runs on ACAP enabled cameras with edge processing capabilities. SAFR Inside reduces network traffic and server overhead and thus lowers overall deployment costs. The first version of SAFR Inside runs on the new AXIS Q1615 Mk III Network Camera announced today.Facial Recognition, Mask Detection and More at a Fraction of the CostSAFR Inside enables network cameras like the AXIS Q1615 Mk III to reduce video processing server overhead and achieve new lows in total cost of ownership. Take the example of a retail grocery chain deploying SAFR for mask detection on a few traditional IP cameras at dozens of locations. Until now, this customer would...

Amarillo to present at virtual John Tumazos Very Independent Research conference on June 23

Written by Customer Service on June 18, 2020. Posted in Public Companies.

TORONTO, June 18, 2020 (GLOBE NEWSWIRE) — Mike Mutchler, President and Chief Executive Officer of Amarillo Gold Corporation (Amarillo or the Company) (TSXV: AGC, OTCQB: AGCBF), will give an update on the Posse Gold Project at the John Tumazos Very Independent Research conference on Tuesday, June 23, 2020 at 10.45 a.m. ET. Posse, located on the Mara Rosa Property in Goiás State, Brazil, is Amarillo’s flagship project.Mutchler’s presentation – Amarillo: Brazil’s next gold producer – will be webcast live via the follow link:https://zoom.us/webinar/register/WN_hhKwxdI2RtC1R-7tVRGBDQ.He will also give an update on Amarillo’s second highly prospective property, Lavras do Sul in Rio Grande do Sul State, Brazil. It has 22,000 hectares of exploration concessions with 22 defined targets centered around historic gold workings. An NI 43-101...

Trupanion Applauds Our Veterinary Heroes on Veterinary Appreciation Day

Written by Customer Service on June 18, 2020. Posted in Public Companies.

SEATTLE, June 18, 2020 (GLOBE NEWSWIRE) — To honor the medical professionals in veterinary hospitals across the world, Trupanion, a leader in medical insurance for cats and dogs, is delivering a virtual standing ovation to those who help the pets we all love receive the best veterinary care.“Veterinary Appreciation Day is a very special day for Trupanion,” said Darryl Rawlings, founder and CEO of Trupanion. “This year, because of social distancing, we had to think differently about how the Trupanion team could honor and thank the veterinary world for helping pets during a challenging time for hospitals. We decided to come together as one team to deliver a virtual standing ovation from the entire company.”Video highlights here: https://www.youtube.com/watch?v=O4DeoU2RIOoVeterinary professionals are the problem solvers, the ones who...

Priviti Oil & Gas Opportunities Limited Partnership 2013 Announces Final Distribution and Fund’s Anticipated Dissolution

Written by Customer Service on June 18, 2020. Posted in Dividend Reports And Estimates.

CALGARY, Alberta, June 18, 2020 (GLOBE NEWSWIRE) — Priviti Capital Corporation, the Investment Fund Manager for Priviti Oil & Gas Opportunities Limited Partnership 2013 (“POGO 2013” or “the Fund”), is pleased to announce that we have sold the remaining investments in Priviti Oil & Gas Opportunities Limited Partnership 2013. The details of the distribution payment are as follows:Distribution rate – $1.05922114/unit for Class A and $1.50645997/unit for Class F unitsRecord date – June 18, 2020Payable date – June 22, 2020Following the Final Distribution, POGO 2013 advises that, pursuant to and in accordance with its limited partnership agreement, the term of POGO 2013 will end and the Fund will be dissolved on June 29, 2020.For further information please contact:Priviti Capital CorporationWard MallabonePresident and CEO1-855-333-9943wmallabone@priviticapital.comAbout...

Cegedim Health Data collabore avec IBM Watson Health pour fournir un accès aux données de vie réelle

Written by Customer Service on June 18, 2020. Posted in Public Companies.

16 juin 2020 – Cegedim Health Data annonce une collaboration avec IBM Watson Health pour l’intégration des données cliniques de vie réelle THIN®, The Health Improvement Network, la base de données patients anonymisées de Cegedim issue des dossiers médicaux électroniques, dans le portefeuille de solutions d’IBM Watson Health. L’intégration de THIN®permettra à IBM Watson Health au travers de sa solution IBM MarketScan® Treatment Pathways d’offrir à ses clients du secteur des sciences de la vie un accès à des données de vie réelle (RWD) européennes, uniques, riches et diversifiées.La base de données THIN®, qui comprend des données cliniques au-delà de la biométrie, telles que les diagnostics, les traitements, les résultats d’examens et les actes médicaux, complètera les bases de données propriétaire d’IBM afin de réaliser des études...

Cegedim Health Data to collaborate with IBM Watson Health to provide integrated access to real world data

Written by Customer Service on June 18, 2020. Posted in Public Companies.

June 16, 2020 – Cegedim Health Data today announced a collaboration with IBM Watson Health to integrate clinical rich real-world data from The Health Improvement Network, THIN®, a Cegedim electronic health record (EHR) database, into IBM Watson Health’s real-world evidence solution portfolio. The integration of THIN®will support IBM Watson Health research services and IBM MarketScan® Treatment Pathways with offering life sciences and pharmaceutical clients access to rich and diverse European real-world data (RWD).The THIN® database, which includes clinical data beyond biometrics such as diagnoses, treatments, clinical outcomes and interventions, will complement IBM’s proprietary databases for use in executing high-quality research studies and a self-service analytic tool to support life sciences clients.“Many life sciences companies...

Month: June 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals